July 06, 2017
GlaxoSmithKline told a North Carolina federal judge Wednesday that it should be allowed to argue in its lawsuit accusing Abbott Laboratories of violating a license agreement by raising the price of an HIV drug that Abbott undervalued some GSK patents in a reciprocal deal.
March 22, 2017
Abbott Laboratories must again face a GlaxoSmithKline suit claiming a price increase violated its license allowing GSK to use an HIV drug, a North Carolina federal court has ruled, finding North Carolina law governs the unfair competition claims and that GSK has sufficiently substantiated those allegations.